netFormulary NHS
South Staffordshire Joint Formulary
Cannock Chase Clinical Commissioning Group
East Staffordshire Clinical Commissioning Group
South East Staffordshire and Seisdon Peninsula Clinical Commissioning Group
Stafford and Surrounds Clinical Commissioning Group
 Search
 Formulary Chapter 6: Endocrine system - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
06.01 Drugs used in diabetes (0,0)
06.01.01 Insulins (0,0)
06.01.01.01 Short-acting insulins (8,6)
Rapid Acting Insulin Analogues (0,0)
06.01.01.02 Intermediate- and long-acting insulins (7,6)
Biphasic insulins (4,3)
Intermediate Acting Insulin (0,0)
Long Acting Insulin Analogues (2,0)
06.01.01.03 Hypodermic equipment (9,7)
06.01.02 Antidiabetic drugs (0,0)
06.01.02.01 Sulphonyureas (1,14)
06.01.02.02 Biguanides (3,3)
06.01.02.03 Other antidiabetic drugs (3,9)
DPP-4 inhibitors (3,0)
GLP-1 mimetics (6,0)
SGLT2 inhibitors (7,0)
06.01.02.07 Other antidiabetic drugs (0,0)
06.01.03 Diabetic ketoacidosis (0,0)
06.01.04 Treatment of hypoglycaemia (1,3)
06.01.05 Treatment of diabetic nephropathy and neuropathy (0,0)
06.01.06 Diagnostic and monitoring agents for diabetes mellitus (2,0)
06.02 Thyroid and Antithyroid drugs (0,0)
06.02.01 Thyroid hormones (3,1)
06.02.02 Antithyroid drugs (2,1)
06.03 Corticosteroids (1,0)
06.03.01 Replacement therapy (1,0)
06.03.02 Glucocorticoid therapy (4,10)
06.04 Sex hormones (0,0)
06.04.01 Female sex hormones and their modulators (0,1)
06.04.01.01 Oestrogens and HRT (9,38)
06.04.01.02 Progestogens (5,10)
06.04.02 Male sex hormones and antagonists (5,10)
Anti-androgens (2,2)
06.04.03 Anabolic steroids (1,1)
06.05 Hypothalamic and pituitary hormones and anti-oestrogens (0,1)
06.05.01 Hypothalamic and anterior pituitary hormones and anti-oestrogens (0,0)
Anti-oestrogens (1,0)
Anterior pituitary hormones (1,12)
Gonadotrophins (0,0)
Growth Hormone (0,0)
Growth hormone receptor antagonists (0,0)
Thyrotropin (0,0)
06.05.02 Posterior pituitary hormones and antagonists (2,0)
Posterior pituitary hormones (1,7)
06.06 Drugs affecting bone metabolism (0,0)
Osteoporosis (0,0)
06.06.01 Calcitonin and parathyroid hormone (3,0)
06.06.02 Bisphosphonates and other drugs affecting bone metabolism (0,0)
Bisphosphonates (9,9)
Denosumab (2,0)
06.07 Other endocrine drugs (0,0)
06.07.01 Bromocriptine and other dopaminergic drugs (0,3)
06.07.02 Drugs affecting gonadotrophins (1,4)
06.07.03 Metyrapone (0,2)
06.07.04 Somatomedins (0,1)
netFormulary